skip to Main Content

Developing a TPMG Pathway for Selective Oncotype DX Testing in Early Breast Cancer

The goal of this project is to determine whether Ki-67 testing, using newer methods, could be used as a replacement for Oncotype DX testing in selected patients with HR+/HER2- breast cancer.

Investigator: Habel, Laurel

Funder: TPMG Delivery Science Projects Program

Explore all studies and publications

Back To Top